Segui
Ankur Kumar
Titolo
Citata da
Citata da
Anno
Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease
A Kumar, B Liang, M Aarthy, SK Singh, N Garg, IU Mysorekar, R Giri
ACS omega 3 (12), 18132-18141, 2018
1032018
Deciphering the dark proteome of Chikungunya virus
A Singh, A Kumar, R Yadav, VN Uversky, R Giri
Scientific reports 8 (1), 1-10, 2018
572018
Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through in-silico approaches
R Yadav, C Selvaraj, M Aarthy, P Kumar, A Kumar, SK Singh, R Giri
Journal of Biomolecular Structure and Dynamics 39 (1), 272-284, 2021
362021
Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions
K Gadhave, P Kumar, A Kumar, T Bhardwaj, N Garg, R Giri
Microbial Pathogenesis 158, 105041, 2021
332021
Understanding the interactability of chikungunya virus proteins via molecular recognition feature analysis
A Singh, A Kumar, VN Uversky, R Giri
RSC advances 8 (48), 27293-27303, 2018
332018
Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study
P Kumar, T Bhardwaj, A Kumar, BR Gehi, SK Kapuganti, N Garg, G Nath, ...
Journal of Biomolecular Structure and Dynamics 40 (7), 3170-3184, 2022
282022
Zika virus NS4A cytosolic region (residues 1–48) is an intrinsically disordered domain and folds upon binding to lipids
A Kumar, P Kumar, R Giri
Virology 550, 27-36, 2020
242020
SARS-CoV-2 NSP1 C-terminal (residues 131–180) is an intrinsically disordered region in isolation
A Kumar, A Kumar, P Kumar, N Garg, R Giri
Current Research in Virological Science 2, 100007, 2021
172021
Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
T Bhardwaj, K Gadhave, SK Kapuganti, P Kumar, ZF Brotzakis, ...
Nature Communications 14 (1), 945, 2023
162023
SARS-CoV-2 NSP1 C-terminal region (residues 130-180) is an intrinsically disordered region
A Kumar, A Kumar, P Kumar, N Garg, R Giri
BioRxiv, 2020
152020
A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells
A Singh, A Kumar, P Kumar, N Nayak, T Bhardwaj, R Giri, N Garg
Journal of Biological Chemistry 297 (1), 2021
142021
Zika virus NS4A N-Terminal region (1-48) acts as a cofactor for inducing NTPase activity of NS3 helicase but not NS3 protease
D Kumar, A Kumar, T Bhardwaj, R Giri
Archives of Biochemistry and Biophysics 695, 108631, 2020
102020
Experiments and simulation on ZIKV NS2B-NS3 protease reveal its complex folding
A Kumar, P Kumar, M Aarthy, SK Singh, R Giri
Virology 556, 110-123, 2021
62021
Conformational dynamics of NSP11 peptide of SARS-CoV-2 under membrane mimetics and different solvent conditions
K Gadhave, P Kumar, A Kumar, T Bhardwaj, N Garg, R Giri
BioRxiv, 2020.10. 07.330068, 2021
52021
Environmental dependence of the structure of the c-terminal domain of the SARS-CoV-2 envelope protein
K Gadhave, A Kumar, P Kumar, SK Kapuganti, N Garg, M Vendruscolo, ...
bioRxiv, 2020
52020
Drugs to limit Zika virus infection and implication for maternal-fetal health
AA Kumar, D Kumar, J Jose, R Giri, IU Mysorekar
Frontiers in Virology, 64, 2022
42022
Salvianolic acid B noncovalently interacts with disordered c-Myc: a computational and spectroscopic-based study
A Singh, A Kumar, P Kumar, T Bhardwaj, R Giri, N Garg
Future Medicinal Chemistry 13 (16), 1341-1352, 2021
32021
One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding
P Kumar, T Bhardwaj, A Kumar, N Garg, R Giri
Journal of Biomolecular Structure and Dynamics, 1-8, 2021
22021
Curcumin Inhibits Zika Virus NS3 Helicase Activity
A Kumar, A Bhardwaj, R Joshi, T Bhardwaj, R Giri
bioRxiv, 2024.01. 03.573903, 2024
2024
The multi-protein targeting potential of bioactive syringin in inflammatory diseases: using molecular modelling and in-silico analysis of regulatory elements
VK Singh, DC Thakur, N Rajak, A Mishra, A Kumar, R Giri, N Garg
Journal of Biomolecular Structure and Dynamics, 1-12, 2023
2023
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20